Sarin Chan
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
-
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
Papers in
-
- Tuberculosis Research and Epidemiology 4
- Parasitic Diseases Research and Treatment 1
- Surgery 2
- Infectious Diseases and Tuberculosis 2
- Co-authors
- D A Mitchison (3 shared papers)Laurence Borand (4 shared papers)Didier Laureillard (3 shared papers)Jean‐François Delfraissy (3 shared papers)Olivier Marcy (4 shared papers)Anne E. Goldfeld (3 shared papers)Sok Thim (3 shared papers)K M Kam (1 shared paper)
In The Last Decade
Sarin Chan
10 papers receiving 282 citations
Peers
Comparison fields: 5 of 46
- Infectious Diseases 188
- Epidemiology 125
- Surgery 112
- Parasitology 10
- Microbiology 1
Countries citing papers authored by Sarin Chan
This map shows the geographic impact of Sarin Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarin Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarin Chan more than expected).
Fields of papers citing papers by Sarin Chan
This network shows the impact of papers produced by Sarin Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarin Chan. The network helps show where Sarin Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarin Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 65 | |
| 2 | 1992 | 57 | |
| 3 | Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. | 2002 | 44 |
| 4 | 2014 | 40 | |
| 5 | 2019 | 27 | |
| 6 | 2014 | 25 | |
| 7 | 2020 | 19 | |
| 8 | Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. | 1997 | 13 |
| 9 | 1994 | 13 | |
| 10 | 2011 | 1 |
About Sarin Chan
Sarin Chan is a scholar working on Infectious Diseases, Surgery, Epidemiology, Psychiatry and Mental health and Molecular Biology, having authored 10 papers that have together received 304 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Epilepsy research and treatment (1 paper), Parasitic Diseases Research and Treatment (1 paper), Mycobacterium research and diagnosis (1 paper) and Parasites and Host Interactions (1 paper). The work is most often cited by research in Infectious Diseases (188 citations), Epidemiology (125 citations), Surgery (112 citations), Parasitology (10 citations) and Microbiology (1 citation). Sarin Chan has collaborated with scholars based in Cambodia, France and China. Frequent co-authors include D A Mitchison, Laurence Borand, Didier Laureillard, Jean‐François Delfraissy, Olivier Marcy, Anne E. Goldfeld, Sok Thim, K M Kam, Yoann Madec and Ruth Goodall. Their work appears in journals such as AIDS, Clinical Infectious Diseases, Emerging infectious diseases, BMC Pulmonary Medicine and BMC Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.